Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last $27.75 USD
Change Today +1.02 / 3.82%
Volume 288.4K
GHDX On Other Exchanges
As of 8:10 PM 08/28/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Kimberly J. Popovits

Chairman, Chief Executive Officer, President and Member of Non-Management Stock Option Committee,Genomic Health Inc.
AgeTotal Calculated CompensationThis person is connected to 12 board members in 2 different organizations across 4 different industries.

See Board Relationships
As of Fiscal Year 2014


Ms. Kimberly J. Popovits, also known as Kim, has been the Chief Executive Officer and President of Genomic Health Inc. since January 2009 and February 2002 respectively. Ms. Popovits served as the Chief Operating Officer at Genomic Health Inc. from February 2002 to January 2009. She has over twenty years of Pharmaceutical and Biopharmaceutical experience. She served in various roles at Genentech, Inc., as Senior Vice President of Marketing and Sales from February 2001 ...

Read Full Background

Corporate Headquarters*

301 Penobscot Drive
Redwood City, California 94063

United States

Phone: 650-556-9300
Fax: --

Board Members Memberships*

Chairman, Chief Executive Officer, President and Member of Non-Management Stock Option Committee
Independent Director


Michigan State University

Other Affiliations*

Annual Compensation*

Total Annual Compensation$660,000

Stock Options*

Restricted Stock Awards$467,040
Exercised Options27,800
Exercised Options Value$440,823
Exercisable Options409,431
Exercisable Options Value$4,282,809
Unexercisable Options163,282
Unexercisable Options Value$336,709
Total Value of Options$5,060,341
Total Number of Options600,513

Total Compensation*

Total Annual Cash Compensation$1,122,800
Total Short Term Compensation$660,000
Other Long Term Compensation$467,040
Total Calculated Compensation$3,031,462
*Data is at least as current as the most recent Definitive Proxy.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
GHDX:US $27.75 USD +1.02


Elazar Rabbani Ph.D.Co-Founder, Chairman, Chief Executive Officer and Secretary
Enzo Biochem Inc.
Douglas M. VanOort Executive Chairman and Chief Executive Officer
Neogenomics Inc.
Percy C. Tomlinson Jr.Chief Executive Officer, President and Director
Alliance Healthcare Services, Inc.
R. Bradley Gray Chief Executive Officer, President and Director
NanoString Technologies, Inc.
Michael J. Pellini M.D., MBAChief Executive Officer and Director
Foundation Medicine, Inc.
Compensation as of Fiscal Year 2014.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact GENOMIC HEALTH INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at